SCS
AGN

Syquant Capital SAS’s Allergan plc AGN Stock Holding History

Syquant Capital SAS’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,080,922
Closed -$191M – 31
2020
Q1 		$191M Buy
1,080,922
+1,025,422
+1,848% +$193M 47.02% 1
2019
Q4 		$10.6M Buy
+55,500
New +$10M 5.46% 7

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Syquant Capital SAS's AGN Position: Q2 2020 in Review

Syquant Capital SAS sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,080,922 shares — an estimated $191M sold.

Syquant Capital SAS first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $191M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Syquant Capital SAS reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Syquant Capital SAS sold 1,080,922 Allergan plc shares in Q2 2020, an estimated $191M.
  • Syquant Capital SAS first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Syquant Capital SAS's Allergan plc position peaked at $191M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Syquant Capital SAS's 13F filing for Q2 2020, filed 5 Aug 2020.